These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18769484)

  • 1. Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs-a multi-centre, randomized controlled trial.
    Scherbaum WA; Ohmann C; Abholz HH; Dragano N; Lankisch M
    PLoS One; 2008 Aug; 3(8):e3087. PubMed ID: 18769484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.
    Guerci B; Drouin P; Grangé V; Bougnères P; Fontaine P; Kerlan V; Passa P; Thivolet Ch; Vialettes B; Charbonnel B;
    Diabetes Metab; 2003 Dec; 29(6):587-94. PubMed ID: 14707887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
    Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
    BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events.
    Farmer A; Balman E; Gadsby R; Moffatt J; Cradock S; McEwen L; Jameson K
    Curr Med Res Opin; 2008 Nov; 24(11):3097-104. PubMed ID: 18828957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).
    Barnett AH; Krentz AJ; Strojek K; Sieradzki J; Azizi F; Embong M; Imamoglu S; Perusicová J; Uliciansky V; Winkler G
    Diabetes Obes Metab; 2008 Dec; 10(12):1239-47. PubMed ID: 18494813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mobile phone application combined with or without self-monitoring of blood glucose on glycemic control in patients with diabetes: A randomized controlled trial.
    Yu Y; Yan Q; Li H; Li H; Wang L; Wang H; Zhang Y; Xu L; Tang Z; Yan X; Chen Y; He H; Chen J; Feng B
    J Diabetes Investig; 2019 Sep; 10(5):1365-1371. PubMed ID: 30815973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control.
    Meier JL; Swislocki AL; Lopez JR; Noth RH; Bartlebaugh P; Siegel D
    Am J Manag Care; 2002 Jun; 8(6):557-65. PubMed ID: 12068962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986].
    Polonsky W; Fisher L; Schikman C; Hinnen D; Parkin C; Jelsovsky Z; Amstutz L; Schweitzer M; Wagner R
    BMC Fam Pract; 2010 May; 11():37. PubMed ID: 20482765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-monitoring of blood glucose (SMBG) improves glycaemic control in oral hypoglycaemic agent (OHA)-treated type 2 diabetes (SMBG-OHA study).
    Harashima S; Fukushima T; Sasaki M; Nishi Y; Fujimoto S; Ogura M; Yamane S; Tanaka D; Harada N; Hamasaki A; Nagashima K; Nakahigashi Y; Seino Y; Inagaki N
    Diabetes Metab Res Rev; 2013 Jan; 29(1):77-84. PubMed ID: 23008090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
    Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
    J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
    Puhr S; Calhoun P; Welsh JB; Walker TC
    Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin.
    Kempf K; Tankova T; Martin S
    Diabetes Technol Ther; 2013 Jan; 15(1):89-96. PubMed ID: 23194054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of glycaemia control in subjects with type 2 diabetes by self-monitoring of blood glucose: comparison of two management programs adjusting bedtime insulin dosage.
    Chen HS; Wu TE; Jap TS; Lin SH; Hsiao LC; Lin HD
    Diabetes Obes Metab; 2008 Jan; 10(1):34-40. PubMed ID: 18095948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.
    Malanda UL; Welschen LM; Riphagen II; Dekker JM; Nijpels G; Bot SD
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005060. PubMed ID: 22258959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study.
    Polonsky WH; Fisher L; Schikman CH; Hinnen DA; Parkin CG; Jelsovsky Z; Axel-Schweitzer M; Petersen B; Wagner RS
    Diabetes Technol Ther; 2011 Aug; 13(8):797-802. PubMed ID: 21568751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5).
    Schneider B; Martin S; Heinemann L; Lodwig V; Kolb H
    Arzneimittelforschung; 2007; 57(12):762-9. PubMed ID: 18380408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.